2.32

2.86% -0.0683

After Hours: 2.28 -0.04 -1.72%

Vivosim Labs Inc (VIVS)

Overview News Price History Discussions Forecast

Vivosim Labs Inc stock is traded at $2.32, with a volume of 18,845. It is down -2.86% in the last 24 hours and up +1.75% over the past month. VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.

Previous Close:

$2.3883

Open:

$2.38

24h Volume:

18,845

Relative Volume:

0.04

Market Cap:

$6.05M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+3.57%

1M Performance:

+1.75%

6M Performance:

+26.43%

1Y Performance:

+0.00%

1-Day Range:

$2.29

$2.38

1-Week Range:

$2.11

$2.401

52-Week Range:

$1.41

$5.30

Vivosim Labs Inc Stock (VIVS) Company Profile

Name

Vivosim Labs Inc

Sector

Healthcare (1133)

Industry

Biotechnology (634)

Phone

858-224-1000

Address

11555 SORRENTO VALLEY ROAD, SAN DIEGO

Employee

Twitter

Next Earnings Date

Latest SEC Filings

VIVS's Discussions on Twitter

Compare VIVS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VIVS Vivosim Labs Inc	2.32	5.97M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	455.48	116.04B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	718.36	75.97B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	458.12	61.48B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	901.17	56.40B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	204.00	43.73B	447.02M	-1.18B	-906.14M	-6.1812

Vivosim Labs Inc Stock (VIVS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-13-18	Initiated	H.C. Wainwright	Buy
Nov-10-17	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-25-17	Initiated	Raymond James	Outperform
Aug-11-15	Downgrade	Cantor Fitzgerald	Buy → Hold
Jun-29-15	Initiated	Jefferies	Buy
Jun-29-15	Initiated	Piper Jaffray	Overweight

View All

Vivosim Labs Inc Stock (VIVS) Latest News

Dec 04, 2025

Can VivoSim Labs Inc. (4OR) stock stage a strong rebound this quarter2025 Risk Factors & Expert Approved Trade Ideas - Newser

Dec 04, 2025

How VivoSim Labs Inc. (4OR) stock reacts to monetary easingJuly 2025 Short Interest & Long-Term Growth Plans - Newser

Dec 04, 2025

What valuation ratios show for VivoSim Labs Inc. (4OR) stockJuly 2025 Snapshot & Reliable Entry Point Trade Alerts - Newser

Dec 04, 2025

Can VivoSim Labs Inc. (4OR) stock hit consensus price targetsQuarterly Portfolio Summary & Technical Confirmation Trade Alerts - Newser

Dec 04, 2025

Will VivoSim Labs Inc. (4OR) stock beat international competitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - Newser

Dec 04, 2025

How interest rate cuts could boost VivoSim Labs Inc. stockMarket Sentiment Summary & Proven Capital Preservation Methods - Newser

Dec 04, 2025

Dec 03, 2025

What consensus target says about VivoSim Labs Inc. (4OR) stockPortfolio Value Report & Verified Chart Pattern Signals - Newser

Dec 03, 2025

Dec 02, 2025

VivoSim Labs (VIVS) Competitors and Alternatives 2025 - MarketBeat

Dec 02, 2025

Will VivoSim Labs Inc. (4OR) stock beat revenue estimatesEarnings Growth Report & Real-Time Volume Analysis - Newser

Dec 02, 2025

Will VivoSim Labs Inc. (4OR) stock split increase liquidity - Newser

Dec 02, 2025

Nov 29, 2025

Momentum Shift: Is VivoSim Labs Inc. stock a safe investment in uncertain marketsWeekly Volume Report & Consistent Growth Stock Picks - BỘ NỘI VỤ

Nov 29, 2025

Nov 27, 2025

Why retail investors favor VivoSim Labs Inc. stockMarket Risk Report & Daily Growth Stock Investment Tips - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

Why VivoSim Labs Inc. stock could outperform in 2025Market Risk Report & Expert Verified Movement Alerts - BỘ NỘI VỤ

Nov 26, 2025

Nov 21, 2025